Inventor

Robert Kiss

Inventor
Sint-Pieters-Leeuw, BE

Overview

18→
Patents
1993–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds22%
A61KPreparations for medical, dental or toiletry purposes13%
C12NMicroorganisms or enzymes9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07JSteroids4%
B82YSpecific uses or applications of nanostructures2%
C07CAcyclic or carbocyclic compounds2%
C07HSugars2%
C07KPeptides2%
PatentTitleYear
11,034,793Methods of preparing a poloxamer for use in cell culture medium202110,184,106Methods for viral inactivation and other adventitious agents20199,493,744'Methods for viral inactivation and other adventitious agents'20169,181,265'Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents'20159,168,247'Beta carboline derivatives useful in the treatment of proliferative disorders'20158,772,265'Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy'20147,981,875'2″ oxo-voruscharin and derivatives thereof'20117,964,575'Use of a galectin-1-targeted RNAi-based approach for the treatment of cancer'20117,741,337'Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom'20107,320,971'2″ oxo-voruscharin and derivatives thereof'20086,809,096'Phenanthroline-7-one derivatives and their therapeutic uses'20046,645,983'Pharmaceutical compositions comprising 4-quinolones for treating cancers'20036,593,342'Pharmaceutical compositions comprising 2-quinolones'20036,583,150'Pharmaceutical composition based on polyaromatic compounds'20036,265,423'Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions'20015,643,885'Etoposide derivatives, process for preparing them, their use as a medicinal product and their use for the preparation of a medicinal product intended for anti-cancer treatment'19975,620,985'Antimitotic binary alkaloid derivatives from catharanthus roseus'19975,182,273'Spirocyclic N, O derivatives of cyclotriphosphazenes and their use in therapy'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1997Patents assigned to PF MEDICAMENT (3)· patent assignee history
1997–2004Based in Wauthier-Braine, BE· patent location history
1997–2003Based in Brussels, BE· patent location history
2003–2004Patents assigned to LAFON LABOR (4)· patent assignee history
2008–2015Based in Sint-Pieters-Leeuw, BE· patent location history
2011–2015Patents assigned to UNIV BRUXELLES (4)· patent assignee history
2014–2015Patents assigned to KISS ROBERT (3)· patent assignee history
2016–2021Patents assigned to GENENTECH INC (3)· patent assignee history
2016–2019Based in San Mateo, CA, US· patent location history
2021Based in South San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
LAFON LABOR42003–2004
UNIV BRUXELLES42011–2015
GENENTECH INC32016–2021
KISS ROBERTself32014–2015
PF MEDICAMENT31993–1997
Locations
LocationPatentsSpan
Sint-Pieters-Leeuw, BE72008–2015
Wauthier-Braine, BE51997–2004
San Mateo, California, US22016–2019
Brussels, BE21997–2003
South San Francisco, California, US12021